24464-41-3 Usage
Description
7-phenyl-1,2,3,4-tetrahydroisoquinoline is a chemical compound with a molecular formula C16H15N. It is a colorless to pale yellow liquid that is soluble in organic solvents. 7-phenyl-1,2,3,4-tetrahydroisoquinoline is commonly used in the synthesis of pharmaceuticals and as a building block in organic chemistry. It has been studied for its potential medicinal properties, including its potential as an anti-inflammatory and analgesic agent. Additionally, 7-phenyl-1,2,3,4-tetrahydroisoquinoline has been investigated for its neuroprotective and antioxidant effects, making it a compound of interest in the field of medicinal chemistry.
Uses
Used in Pharmaceutical Synthesis:
7-phenyl-1,2,3,4-tetrahydroisoquinoline is used as a building block in the synthesis of various pharmaceuticals due to its unique chemical structure and reactivity.
Used in Medicinal Chemistry Research:
7-phenyl-1,2,3,4-tetrahydroisoquinoline is used as a compound of interest in medicinal chemistry research for its potential anti-inflammatory and analgesic properties, as well as its neuroprotective and antioxidant effects.
Used in Organic Chemistry:
7-phenyl-1,2,3,4-tetrahydroisoquinoline is used as a versatile building block in organic chemistry for the development of new compounds and materials.
Check Digit Verification of cas no
The CAS Registry Mumber 24464-41-3 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 2,4,4,6 and 4 respectively; the second part has 2 digits, 4 and 1 respectively.
Calculate Digit Verification of CAS Registry Number 24464-41:
(7*2)+(6*4)+(5*4)+(4*6)+(3*4)+(2*4)+(1*1)=103
103 % 10 = 3
So 24464-41-3 is a valid CAS Registry Number.
24464-41-3Relevant articles and documents
Ruthenium-catalyzed chemo-and enantioselective hydrogenation of isoquinoline carbocycles
Jin, Yushu,Makida, Yusuke,Uchida, Tatsuya,Kuwano, Ryoichi
, p. 3829 - 3839 (2018/04/14)
A chemoselective hydrogenation of isoquinoline carbocycles was achieved by using the catalyst prepared from Ru(methallyl)2(cod) and trans-chelate chiral ligand PhTRAP. The unique chemoselectivity achieved in this hydrogenation could be ascribed to the trans-chelation of the chiral ligand. The procedure for preparing the catalyst strongly affects the reproducibility of the carbocycle hydrogenation. Various 5-, 6-, 7-, and 8-substituted isoquinolines were selectively hydrogenated at their carbocycles to afford 5,6,7,8-tetrahydroisoquinolines as major products in high yields with moderate or good enantioselectivities. Some mechanistic studies suggested that the stereogenic center was created during the initial addition of H2 to the aromatic ring in the hydrogenation of 5-substituted isoquinolines. In other words, the stereochemical control was accompanied by the dearomatization.
Pyridine, pyrimidine, quinoline, quinazoline, and naphthalene urotensin-II receptor antagonists
-
, (2008/06/13)
The present invention relates to urotensin II receptor antagonists, pharmaceutical compositions containing them and their use.
PYRROLO-PYRIDINE DERIVATIVES
-
, (2008/06/13)
Compounds of formula I are ligands for dopamine receptor subtypes within the body and are therefore useful in the treatment and/or prevention of disorders of the dopamine system, in particular schizophrenia. STR1 wherein Q is STR2